1. Home
  2. TASK vs CNTA Comparison

TASK vs CNTA Comparison

Compare TASK & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TASK
  • CNTA
  • Stock Information
  • Founded
  • TASK 2008
  • CNTA 2020
  • Country
  • TASK United States
  • CNTA United Kingdom
  • Employees
  • TASK N/A
  • CNTA N/A
  • Industry
  • TASK Retail: Computer Software & Peripheral Equipment
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TASK Technology
  • CNTA Health Care
  • Exchange
  • TASK Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • TASK 1.5B
  • CNTA 1.6B
  • IPO Year
  • TASK 2021
  • CNTA 2021
  • Fundamental
  • Price
  • TASK $16.87
  • CNTA $14.29
  • Analyst Decision
  • TASK Buy
  • CNTA Strong Buy
  • Analyst Count
  • TASK 6
  • CNTA 10
  • Target Price
  • TASK $17.67
  • CNTA $28.78
  • AVG Volume (30 Days)
  • TASK 227.6K
  • CNTA 980.2K
  • Earning Date
  • TASK 08-07-2025
  • CNTA 08-12-2025
  • Dividend Yield
  • TASK N/A
  • CNTA N/A
  • EPS Growth
  • TASK 15.14
  • CNTA N/A
  • EPS
  • TASK 0.60
  • CNTA N/A
  • Revenue
  • TASK $1,045,307,000.00
  • CNTA $15,000,000.00
  • Revenue This Year
  • TASK $14.37
  • CNTA N/A
  • Revenue Next Year
  • TASK $8.00
  • CNTA N/A
  • P/E Ratio
  • TASK $28.18
  • CNTA N/A
  • Revenue Growth
  • TASK 14.05
  • CNTA 118.88
  • 52 Week Low
  • TASK $10.57
  • CNTA $9.00
  • 52 Week High
  • TASK $19.60
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • TASK 59.29
  • CNTA 61.38
  • Support Level
  • TASK $16.68
  • CNTA $13.22
  • Resistance Level
  • TASK $16.99
  • CNTA $14.74
  • Average True Range (ATR)
  • TASK 0.13
  • CNTA 0.73
  • MACD
  • TASK -0.04
  • CNTA 0.14
  • Stochastic Oscillator
  • TASK 68.10
  • CNTA 85.11

About TASK TaskUs Inc.

TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: